NCCN Patient Webinar: Diffuse Large B-Cell Lymphoma
Experts provide information and answer questions about diffuse large B-cell lymphoma to help patients and caregivers compare, discuss, and select treatment options with their doctor. See list below for topics discussed. Please note that this is a not an accredited activity.
Topics Discussed:
0:00 - Welcome and Introductions
1:50 - Diagnosis and Prognosis
15:21 - Initial Treatment Approaches
22:04 - Novel Approaches to Relapsed Disease
40:39 - Expectations of Side Effects
53:21 - Navigating Treatment in the COVID Era
58:03 - Shared Decision-Making
1:08:20 - Question and Answer Session
1:20:29 - Closing Remarks
Question and Answer Session:
1:08:33 - What percentage of patients experience neuropathy?
1:10:24 - Discuss administering prophylactic therapy to prevent CNS recurrence in patients that have lymphoma involving deep face structures
1:12:53 - No COVID antibodies detected after 2 shots and a booster, should I get another vaccine?
1:14:37 - After three years remission from DLBCL following six RCHOP-21, my wife was Dx'd with FL, unknown whether this is a newly developed NHL or if she had it all along but hidden behind DLBCL. Is this common and which situation is the most likely? Currently she is on W&W with annual scans for the FL.
1:16:35 - I have stage 2 follicular lymphoma (FL). Is what you discussed applicable?
1:17:38 - Should I be concerned if my oncologist didn't recommended the booster shot of the COVID vaccine?
1:18:13 - How do you measure T-Cell antibodies?
1:18:50 - CNS involvement in DLBCL
1:20:04 - Can the COVID vaccine cause lymphoma?
The Patient Webinars: Diffuse Large B-Cell Lymphoma occurred in October 2021. This informational program was created in conjunction with the recently updated NCCN Guidelines for Patients® for Diffuse Large B-Cell Lymphoma. (https://www.nccn.org/patientresources...)
The NCCN Guidelines for Patients (http://nccn.org/patientguidelines) are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.
NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.
Supporters:
This webinar program is supported through the NCCN Foundation, by contributions from our corporate supporters Incyte Corporation and MorphoSys US Inc.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.
Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?s...
Connect with us!
Twitter: / nccn
LinkedIn: / nccn
Facebook: / nccnorg
Instagram: / nccnorg